To substantiate these findings, we then studied the association of IGF-1R expression (by immunohistochemistry (IHC) in 440 breast tumor specimen) with ERα/Src and ERα/PI3K expression, two markers already shown to be strongly correlated with nongenomic mERα signaling in a previous study [5]. The gene discussed is ESR1; the disease is breast neoplasm.